Sfoglia per AUTORE
PROCACCI C
Collezione ASL Vercelli
Items : 14
Evaluation of biochemical and economic outcomes in patients treated with PCSK9 inhibitors in a real clinical practice setting in Minerva Cardiology and Angiology
2025
ASL Vercelli
Dovizio M; Nugnes M; Iacolare B; Nappi C; Saragoni S; Andretta M; Barbieri A; Bartolini F; Chinellato G; Cillo M; Dell’Orco S; Grego S; Lavalle A; Procacci C; Re D; Degli Esposti L;
Gender differences and hypercholesterolemia: real-world evidence from the study WECARE (Women Effective CArdiovascular Risk Evaluation) in Global and Regional Health Technology Assessment
2024
ASL VCO
ASL Vercelli
Perrone V; Medea G; Urbinati S; Sangiorgi D; Esposti LD; Andretta M; Bacca M; Barbieri A; Bartolini F; Caputo M; Cavaliere A; Ciaccia A; Costantini A; Ferrante F; Gentile S; Grego S; Lavalle A; Lupi A; Maccio S; Mancini D; Moscogiuri R; Procacci C; Re D; Santoleri F;
Profile, Healthcare Resource Consumption and Related Costs in ANCA-Associated Vasculitis Patients: A Real-World Analysis in Italy in Advances in Therapy
2023
ASL Vercelli
Degli Esposti L; Dovizio M; Perrone V; Veronesi C; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo M; Citraro R; Costantini A; Dell’Orco S; Ferrante F; Gentile S; Grego S; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Ramirez de Arellano A; Gigliotti G; et alii...
Analysis of outcomes and healthcare resource consumption in patients with ANCA-associated vasculitis in a setting of clinical practice in Italy. in Giornale Italiano di Farmacia Clinica
2023
ASL Vercelli
Dovizio M; Perrone V; Veronesi C; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Dell’Orco S; Ferrante F; Gallo L; Gentile S; Grego S; Lavalle A; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Procacci C; Re D; Ubertazzo L; Vercellone A; Gigliotti G; Quartuccio L; Espositi LD;
HSD64 Drug Discontinuation and Healthcare Cost Evaluation in Crohn's Disease Patients Under Biologic Therapy: An Italian Retrospective Analysis in Value in Health
2022
ASL Vercelli
Perrone V; Secchi O; Serra A; Franchi A; Dovizio M; Sangiorgi D; Andretta M; Antonacci S; Barbieri A; Bartolini F; Cavaliere A; Ciaccia A; Cillo MR; Citraro R; Costantini A; Dell'Orco S; Grego S; Moscogiuri R; Mosele E; Procacci C; Santoleri F; Vercellone A; Degli Esposti L;
Clinical Profile and Healthcare Resource Use of ANCA-Associated Vasculitis: A Real-World Analysis in Italy in Value in Health
2022
ASL Vercelli
Perrone V; Dovizio M; Veronesi C; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Costantini A; Dell'Orco S; Ferrante F; Gentile S; Grego S; Lavalle A; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Ramirez de Arellano Serna A; Degli Esposti L; et alii...
HSD61 Trends in Discontinuation of Lipid-Lowering and Antihypertensive Therapies: A Real-World Data Analysis in Italy in Value in Health
2022
ASL Vercelli
Dovizio M; Perrone V; Iacolare B; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Costantini A; Dell'Orco S; Ferrante F; Gentile S; Grego S; Lavalle A; Maccio S; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Pastorello M; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Degli Esposti L; et alii...
HSD16 PCSK-9 Inhibitors for the Control of Hypercholesterolemia: Eligibility for Treatment, Prescription Appropriateness and Outcomes, in a Real-World Clinical Setting in Value in Health
2022
ASL Vercelli
Perrone V; Iacolare B; Dovizio M; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Costantini A; Dell'Orco S; Ferrante F; Gentile S; Grego S; Lavalle A; Maccio S; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Pastorello M; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Degli Esposti L; et alii...
POSA310 Artificial Intelligence Applied on Administrative Big Data to Predict the Severity of SARS-COV-2 Infection in Value in Health
2022
ASL Vercelli
Iacolare B; Perrone V; Sangiorgi D; Ghigi A; Giacomini E; Nappi C; Paoli D; Ancona DD; Andretta M; Barbieri A; Bartolini F; Cavaliere A; Ciaccia A; Citraro R; Dell'Orco S; Ferrante F; Gentile S; Grego S; Procacci C; Ubertazzo L; Vercellone A; Degli Esposti L;
P2 Estimation of Metastatic Colorectal Cancer Patients Carrying BRAF Mutation Potentially Eligible to Targeted Therapy: A Real-World Evidence Study in Italy in Value in Health
2022
ASL Vercelli
Degli Esposti L; Sangiorgi D; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Costantini A; De Francesco A; Enieri N; Ferrante F; Gentile S; Lavalle A; Mancini D; Mensurati M; Moscogiuri R; Pastorello M; Procacci C; Re D; Santoleri F; Serao Creazzola S; Tegon M; Ubertazzo L; Vercellone A; Perrone V; et alii...
2022
ASL Vercelli
Degli Esposti L; Sangiorgi D; Ancona DD; Andretta M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Costantini A; De Francesco A; Dell'Orco S; Di Manno G; Ferrante F; Gentile S; Lavalle A; Moscogiuri R; Pastorello M; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Perrone V;
P1 Data-Linkage Between Administrative and Pathological Anatomy Databases for the Identification of Lung Cancer Patients Eligible to Innovative Therapies in Value in Health
2022
ASL Vercelli
Degli Esposti L; Sangiorgi D; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Costantini A; De Francesco A; Ferrante F; Gentile S; Lavalle A; Mancini D; Mensurati M; Moscogiuri R; Pastorello M; Procacci C; Re D; Santoleri F; Serao Creazzola S; Ubertazzo L; Vercellone A; Perrone V;
POSC156 Clinical Burden, Treatment Pathway, and Healthcare Resource Utilization of Transfusion-Dependent Beta-Thalassemia Patients in Italy: A Retrospective Analysis in Value in Health
2022
ASL Vercelli
Perrone V; Veronesi C; Giacomini E; Ancona DD; Andretta M; Barbieri A; Bartolini F; Bianco D; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Dell'Orco S; Ferrante F; Gentile S; Serao Creazzola S; Pastorello M; Procacci C; Re D; Tegon M; Ubertazzo L; Vercellone A; Degli Esposti L;
Cardiovascular Events and Mortality in Type-2 Diabetic Patients under Second-Line Treatment with Hypoglycemic Agents: An Italian Real-World Study in Value in Health
2022
ASL Vercelli
Degli EL; Sangiorgi D; Nappi C; Andretta M; Barbieri A; Citraro R; Bartolini F; Cavaliere A; Ciaccia A; Chinellato A; Cillo MR; Dell'Orco S; Ferrante F; Gentile S; Procacci C; Re D; Ubertazzo L; Vercellone A; Perrone V;